Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 5.22M
2: EX-4.29 Instrument Defining the Rights of Security Holders HTML 57K
3: EX-10.22 Material Contract HTML 238K
4: EX-10.45 Material Contract HTML 72K
5: EX-10.47 Material Contract HTML 62K
6: EX-10.53 Material Contract HTML 99K
7: EX-10.54 Material Contract HTML 118K
8: EX-21.1 Subsidiaries List HTML 182K
9: EX-23.1 Consent of Expert or Counsel HTML 43K
14: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 52K
Awarded Compensation
10: EX-31.1 Certification -- §302 - SOA'02 HTML 47K
11: EX-31.2 Certification -- §302 - SOA'02 HTML 47K
12: EX-32.1 Certification -- §906 - SOA'02 HTML 44K
13: EX-32.2 Certification -- §906 - SOA'02 HTML 44K
20: R1 Cover Page HTML 109K
21: R2 Audit Information HTML 48K
22: R3 Consolidated Statements of Operations HTML 162K
23: R4 Consolidated Statements of Comprehensive Income HTML 86K
24: R5 Consolidated Balance Sheets HTML 198K
25: R6 Consolidated Balance Sheets (Parenthetical) HTML 65K
26: R7 Consolidated Statements of Cash Flows HTML 163K
27: R8 Consolidated Statements of Cash Flows HTML 44K
(Parenthetical)
28: R9 Consolidated Statements of Shareholders' Equity HTML 128K
29: R10 Consolidated Statements of Shareholders' Equity HTML 49K
(Parentheticals)
30: R11 Significant Accounting Policies HTML 427K
31: R12 Acquisitions, Divestitures and Asset Sales HTML 114K
32: R13 Restructuring Program HTML 51K
33: R14 Investments HTML 342K
34: R15 Fair Value HTML 236K
35: R16 Goodwill and Other Intangibles HTML 103K
36: R17 Leases HTML 192K
37: R18 Health Care Costs Payable HTML 95K
38: R19 Other Insurance Liabilities and Separate Accounts HTML 176K
39: R20 Borrowings and Credit Agreements HTML 128K
40: R21 Pension Plans and Other Postretirement Benefits HTML 206K
41: R22 Income Taxes HTML 111K
42: R23 Stock Incentive Plans HTML 123K
43: R24 Shareholders' Equity HTML 71K
44: R25 Other Comprehensive Income (Loss) HTML 102K
45: R26 Earnings Per Share HTML 62K
46: R27 Reinsurance HTML 75K
47: R28 Commitments and Contingencies HTML 96K
48: R29 Segment Reporting HTML 200K
49: R30 Pay vs Performance Disclosure HTML 55K
50: R31 Insider Trading Arrangements HTML 49K
51: R32 Significant Accounting Policies (Policies) HTML 261K
52: R33 Significant Accounting Policies (Tables) HTML 310K
53: R34 Acquisitions, Divestitures and Asset Sales HTML 105K
(Tables)
54: R35 Restructuring Program (Tables) HTML 48K
55: R36 Investments (Tables) HTML 350K
56: R37 Fair Value (Tables) HTML 245K
57: R38 Goodwill and Other Intangibles (Tables) HTML 105K
58: R39 Leases (Tables) HTML 134K
59: R40 Health Care Costs Payable (Tables) HTML 97K
60: R41 Other Insurance Liabilities and Separate Accounts HTML 207K
(Tables)
61: R42 Borrowings and Credit Agreements (Tables) HTML 120K
62: R43 Pension Plans and Other Postretirement Benefits HTML 222K
(Tables)
63: R44 Income Taxes (Tables) HTML 112K
64: R45 Stock Incentive Plans (Tables) HTML 124K
65: R46 Shareholders' Equity (Tables) HTML 64K
66: R47 Other Comprehensive Income (Loss) (Tables) HTML 102K
67: R48 Earnings Per Share (Tables) HTML 61K
68: R49 Reinsurance (Tables) HTML 74K
69: R50 Segment Reporting (Tables) HTML 195K
70: R51 Significant Accounting Policies - Narrative HTML 173K
(Details)
71: R52 Significant Accounting Policies - Cash and Cash HTML 54K
Equivalents, Restricted Cash and Cash Equivalents
(Details)
72: R53 Significant Accounting Policies - Accounts HTML 61K
Receivable (Details)
73: R54 Significant Accounting Policies - Deferred HTML 53K
Acquisition Costs (Details)
74: R55 Significant Accounting Policies - Property and HTML 66K
Equipment (Details)
75: R56 Significant Accounting Policies - Disaggregation HTML 114K
of Revenue (Details)
76: R57 Significant Accounting Policies - Receivables and HTML 48K
Contract Balances (Details)
77: R58 Significant Accounting Policies - Contract HTML 53K
Balances (Details)
78: R59 Significant Accounting Policies - Variable HTML 88K
Interest Entities (Details)
79: R60 Significant Accounting Policies - New Accounting HTML 83K
Pronouncements Recently Adopted (Details)
80: R61 Significant Accounting Policies - Changes in HTML 84K
Balances of Long-duration Insurance Liabilities
(Details)
81: R62 Significant Accounting Policies - Adjustments HTML 231K
Resulting From Applying New Accounting Standard
(Details)
82: R63 Acquisitions, Divestitures and Asset Sales - HTML 125K
Narrative (Details)
83: R64 Acquisitions, Divestitures and Asset Sales - HTML 66K
Schedule of Fair Value of Consideration
Transferred (Details)
84: R65 Acquisitions, Divestitures and Asset Sales - HTML 105K
Schedule of Estimated Fair Values of Assets
Acquired and Liabilities Assumed (Details)
85: R66 Acquisitions, Divestitures and Asset Sales - HTML 67K
Summary of the Valuation of Goodwill Allocated to
Business Segments (Details)
86: R67 Acquisitions, Divestitures and Asset Sales - HTML 64K
Summary of Fair Values and Weighted Average Useful
Lives for Intangible Assets Acquired (Details)
87: R68 Restructuring Program - Narrative (Details) HTML 51K
88: R69 Restructuring Program - Change in Severance and HTML 49K
Employee-related Restructuring Charge Liability
(Details)
89: R70 Investments - Total Investments Schedule (Details) HTML 62K
90: R71 Investments - Narrative (Details) HTML 57K
91: R72 Investments - Debt Securities (Details) HTML 96K
92: R73 Investments - Debt Securities by Maturity HTML 86K
(Details)
93: R74 Investments - Unrealized Loss Position (Details) HTML 119K
94: R75 Investments - Unrealized Loss Position Maturities HTML 106K
(Details)
95: R76 Investments - Mortgage Loans (Details) HTML 50K
96: R77 Investments - Mortgage Loans Credit Ratings HTML 92K
Indicator (Details)
97: R78 Investments - Mortgage Loan Principal Repayments HTML 56K
(Details)
98: R79 Investments - Net Investment Income (Details) HTML 67K
99: R80 Investments - Realized Gains (Details) HTML 50K
100: R81 Fair Value - Measurement on a Recurring Basis HTML 125K
(Details)
101: R82 Fair Value - Changes in Level 3 Financial Assets HTML 95K
(Details)
102: R83 Fair Value - Narrative (Details) HTML 56K
103: R84 Fair Value - Gross Transfers Into (Out of) Level 3 HTML 54K
(Details)
104: R85 Fair Value - Carrying Value and Fair Value HTML 74K
Classified by Level (Details)
105: R86 Fair Value - Separate Accounts Fair Value HTML 81K
(Details)
106: R87 Goodwill and Other Intangibles - Goodwill HTML 68K
(Details)
107: R88 Goodwill and Other Intangibles - Narrative HTML 61K
(Details)
108: R89 Goodwill and Other Intangibles - Intangible Assets HTML 79K
(Details)
109: R90 Goodwill and Other Intangibles - Future HTML 54K
Amortization Expense (Details)
110: R91 Leases - Narrative (Details) HTML 80K
111: R92 Leases - Summary of the Components of Net Lease HTML 62K
Cost (Details)
112: R93 Leases - Supplemental Cash Flow Information HTML 58K
(Details)
113: R94 Leases - Supplemental Balance Sheet Information HTML 89K
(Details)
114: R95 Leases - Maturities of Operating and Finance Lease HTML 104K
Liabilities (Details)
115: R96 Health Care Costs Payable - Incurred and Paid HTML 59K
Health Care Claims Development (Details)
116: R97 Health Care Costs Payable - Narrative (Details) HTML 49K
117: R98 Health Care Costs Payable - Liability for Unpaid HTML 59K
Claims and Claims Adjustment Expense (Details)
118: R99 Health Care Costs Payable - Components of Change HTML 96K
in Health Care Costs Payable (Details)
119: R100 Other Insurance Liabilities and Separate Accounts HTML 122K
- Changes in Liability for Future Policy Benefits
(Details)
120: R101 Other Insurance Liabilities and Separate Accounts HTML 52K
- Undiscounted Expected Gross Premiums and
Expected Future Benefit Payments (Details)
121: R102 Other Insurance Liabilities and Separate Accounts HTML 55K
- Weighted-average Interest Rates and Durations
(Details)
122: R103 Other Insurance Liabilities and Separate Accounts HTML 67K
- Roll Forward of Policyholders' Funds (Details)
123: R104 Other Insurance Liabilities and Separate Accounts HTML 81K
- Separate Account Assets (Details)
124: R105 Other Insurance Liabilities and Separate Accounts HTML 63K
- Roll Forward of Separate Accounts (Details)
125: R106 Borrowings and Credit Agreements - Schedule of HTML 201K
Borrowings (Details)
126: R107 Borrowings and Credit Agreements - Debt Maturities HTML 69K
(Details)
127: R108 Borrowings and Credit Agreements - Short-term HTML 87K
Borrowings (Details)
128: R109 Borrowings and Credit Agreements - Long-term HTML 151K
Borrowings (Details)
129: R110 Pension Plans and Other Postretirement Benefits - HTML 74K
Narrative (Details)
130: R111 Pension Plans and Other Postretirement Benefits - HTML 92K
Benefit Obligations and Plan Assets (Details)
131: R112 Pension Plans and Other Postretirement Benefits - HTML 59K
Net Periodic Benefit Cost (Income) (Details)
132: R113 Pension Plans and Other Postretirement Benefits - HTML 52K
Weighted Average Assumptions Used (Details)
133: R114 Pension Plans and Other Postretirement Benefits - HTML 172K
Fair Value of Pension Plan Assets (Details)
134: R115 Pension Plans and Other Postretirement Benefits - HTML 60K
Changes in Level 3 Pension Plan Assets (Details)
135: R116 Pension Plans and Other Postretirement Benefits - HTML 60K
Defined Benefit Plans Expected Benefit (Details)
136: R117 Income Taxes - Income Tax Provision (Details) HTML 66K
137: R118 Income Taxes - Effective Tax Rate Reconciliation HTML 60K
(Details)
138: R119 Income Taxes - Deferred Tax Assets and Liabilities HTML 84K
(Details)
139: R120 Income Taxes - Narrative (Details) HTML 53K
140: R121 Income Taxes - Unrecognized Tax Benefits (Details) HTML 57K
141: R122 Stock Incentive Plans - Narrative (Details) HTML 115K
142: R123 Stock Incentive Plans - Stock-Based Compensation HTML 56K
Expense (Details)
143: R124 Stock Incentive Plans - Restricted Stock Unit and HTML 75K
Performance Stock Unit Activity (Details)
144: R125 Stock Incentive Plans - Stock Option and SAR HTML 123K
Activity (Details)
145: R126 Stock Incentive Plans - Valuation Assumptions HTML 69K
(Details)
146: R127 Shareholders' Equity - Share Repurchases (Details) HTML 61K
147: R128 Shareholders' Equity - Accelerated Share HTML 78K
Repurchases (Details)
148: R129 Shareholders' Equity - Dividends (Details) HTML 50K
149: R130 Shareholders' Equity - Regulatory Requirements HTML 58K
(Details)
150: R131 Shareholders' Equity - Noncontrolling Interests HTML 48K
(Details)
151: R132 Other Comprehensive Income (Loss) (Details) HTML 121K
152: R133 Earnings Per Share (Details) HTML 86K
153: R134 Reinsurance - Narrative (Details) HTML 47K
154: R135 Reinsurance - Reinsurance Recoverables (Details) HTML 59K
155: R136 Reinsurance - Effects of Reinsurance (Details) HTML 65K
156: R137 Commitments and Contingencies (Details) HTML 77K
157: R138 Segment Reporting - Narrative (Details) HTML 54K
158: R139 Segment Reporting - Retrospective Adjustments to HTML 89K
Segment Composition (Details)
159: R140 Segment Reporting - Reconciliation of Financial HTML 92K
Measures of Segments to Consolidated Totals
(Details)
160: R141 Segment Reporting - Reconciliation from Operating HTML 74K
Income to Adjusted Operating Income (Details)
161: R9999 Uncategorized Items - cvs-20231231.htm HTML 62K
163: XML IDEA XML File -- Filing Summary XML 302K
166: XML XBRL Instance -- cvs-20231231_htm XML 8.02M
162: EXCEL IDEA Workbook of Financial Report Info XLSX 424K
16: EX-101.CAL XBRL Calculations -- cvs-20231231_cal XML 590K
17: EX-101.DEF XBRL Definitions -- cvs-20231231_def XML 2.00M
18: EX-101.LAB XBRL Labels -- cvs-20231231_lab XML 4.37M
19: EX-101.PRE XBRL Presentations -- cvs-20231231_pre XML 2.86M
15: EX-101.SCH XBRL Schema -- cvs-20231231 XSD 426K
164: JSON XBRL Instance as JSON Data -- MetaLinks 1,093± 1.70M
165: ZIP XBRL Zipped Folder -- 0000064803-24-000007-xbrl Zip 1.37M
‘EX-4.29’ — Instrument Defining the Rights of Security Holders
DESCRIPTION OF COMMON STOCK REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
The following description (this “Description”) of the terms of the common stock of CVS Health Corporation (“CVS Health”) is a summary only and is qualified by reference to the relevant provisions of Delaware law and the Restated Certificate of Incorporation (the “Charter”) and the By-Laws
(the “By-Laws”) of CVS Health. Copies of the Charter and the By-Laws are incorporated by reference as exhibits to the Annual Report on Form 10-K to which this Description is an exhibit.
Authorized Capital Stock
Under the Charter as of February 7, 2024, the authorized capital stock of CVS Health consisted of (i) 3,200,000,000 shares of common stock, par value of $0.01 per share (“common stock”), (ii) 120,619 shares of cumulative preferred stock, par value $0.01 per share (“preferred stock”), and (iii) 50,000,000 shares of preference stock, par value $1.00
per share (“preference stock”).
Common Stock
The holders of shares of common stock are entitled to one vote per share on all matters voted on by CVS Health stockholders, including elections of directors. Except as otherwise required by law, or by the provisions of the preferred stock or the preference stock, or provided in any resolution adopted by the CVS Health board of directors (the “board”) with respect to any subsequently created class or series of shares of CVS Health, the holders of the shares of common stock exclusively possess all voting power. The Charter precludes cumulative voting in the election of directors. The Charter provides for a majority vote standard for uncontested elections of directors, and a plurality of votes standard for contested elections of directors. Subject to any rights of any outstanding series of
preferred stock or preference stock, (i) the holders of shares of common stock are entitled to such dividends as may be declared from time to time by the board from funds available therefor, (ii) no dividends may be declared, paid, or set aside for payment on shares of common stock unless full cumulative dividends are paid on any outstanding preference stock and any other preferred stock issued and outstanding at such time that is designated to have such dividend preference and (iii) upon dissolution the holders of shares of common stock are entitled to receive pro rata all assets of CVS Health available for distribution to such holders, subject to any liquidation preferences designated to any preferred stock or preference stock that may be issued and outstanding at such time of liquidation.
No Preemptive Rights
The Charter provides that no holder of any
shares of CVS Health of any class or series may have any preemptive right to purchase or subscribe to any shares of CVS Health or any security convertible into shares of CVS Health of any class or series.
Provisions Relating to Amendments to CVS Health’s Charter and By-Laws
Under Delaware law, stockholders have the right to adopt, amend or repeal the certificate of incorporation and by-laws of a corporation. However, Delaware law requires that any amendment to the Charter also be approved by the board. Under Delaware law, unless a higher vote is required in a corporation’s certificate
of incorporation, amendments to the corporation’s certificate of incorporation will be adopted upon receiving at a properly convened meeting the affirmative vote of a majority of the votes cast by all stockholders entitled to vote thereon, and if any class or series is entitled to vote thereon as a class, the affirmative vote of a majority of the votes cast in each class vote.
In addition, the By-Laws may be amended by the board with respect to all matters not exclusively reserved by law to the stockholders. Amendments to the By-Laws may be adopted and approved by the affirmative vote of the holders of record of a majority of
the outstanding shares of stock of CVS Health entitled to vote at any annual or special meeting, or by the affirmative vote of a majority of the directors cast at any regular or special meeting, at which a quorum is present.
1
Certain Statutory and Charter Provisions
Certain provisions of the Charter and By-Laws summarized in the following paragraphs may be deemed to have an antitakeover effect and may delay, defer or prevent a tender offer or takeover attempt.
Potential Issuances of Preferred Stock and Preference Stock
As of February
7, 2024, the Charter authorized 120,619 shares of preferred stock, par value $0.01 per share and 50,000,000 shares of preference stock, par value $1.00 per share. The Charter also authorizes the board to issue shares of preferred stock or preference stock, from time to time, in such class or classes, and such series within any class, and with such designations, preferences and relative, participating, optional or other special rights, and qualifications, limitations or restrictions thereof as the board may determine, including, for example, (i) the designation of the class or series; (ii) the number of shares of the class or series, which number the board may thereafter (except where otherwise provided in the designation of any subsequently authorized class or series) increase or decrease (but not below the number of shares thereof then outstanding); (iii) whether dividends, if any, will be cumulative or noncumulative and the dividend rate of the class or series;
(iv) the dates on which dividends, if any, will be payable; (v) the redemption rights and price or prices, if any, for shares of the class or series; (vi) the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the class or series; (vii) the amounts payable on shares of the class or series in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of CVS Health; (viii) whether the shares of the class or series will be convertible into shares of any other class or series, or any other security, of CVS Health or any other corporation, and, if so, the specification of such other class or series or such other security, the conversion price or prices or rate or rates, any adjustments thereof, the date or dates as of which such shares will be convertible and all other terms and conditions upon which such conversion may be made; (ix) restrictions on the issuance of shares of the same class or series
or of any other class or series; and (x) the voting rights, if any, of the holders of such class or series. The authorized capital stock of CVS Health, including preferred stock, preference stock and common stock, will be available for issuance without further action by CVS Health stockholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which CVS Health’s securities may be listed or traded. If the approval of CVS Health stockholders is not so required, the board does not intend to seek stockholder approval.
Although the board has no intention at the present time of doing so, it could issue a class or series of preferred stock or preference stock that could, depending on the terms of such class or series, impede completion of a merger, tender offer or other takeover attempt that the holders of some, or a majority, of CVS Health shares might believe to be
in their best interests or in which CVS Health stockholders might receive a premium for their shares over the then-current market price of such shares.
Potential Issuances of Rights to Purchase Securities
CVS Health does not currently have a stockholder rights plan, although the board retains the right to adopt a new plan at a future date. The Charter grants the board exclusive authority to create and issue rights entitling the holders thereof to purchase from CVS Health shares of capital stock or other securities and to elect to repurchase, redeem, terminate or amend any such rights. The times at which and terms upon which such rights are to be issued, repurchased, redeemed, terminated or amended are to be determined exclusively by the board and set forth in the contracts
or instruments that evidence any such rights. The authority of the board with respect to such rights includes determining, for example, (i) the purchase price of the capital stock or other securities or property to be purchased upon exercise of such rights; (ii) provisions relating to the times at which and the circumstances under which such rights may be exercised or sold or otherwise transferred, either together with or separately from any other shares or other securities of CVS Health; (iii) provisions which adjust the number or exercise price of such rights or the amount or nature of the shares, other securities or other property receivable upon exercise of such rights in the event of a combination, split or recapitalization of any shares of CVS Health, a change in ownership of CVS Health’s shares or other securities or a reorganization, merger, consolidation, sale of assets or other occurrence relating to CVS Health or any shares of CVS Health, and provisions restricting
the ability of CVS Health to enter into any such transaction absent an assumption by the other party or parties thereto of the obligations of CVS Health under such rights; (iv) provisions which deny the holder of a specified percentage of the outstanding securities of CVS Health the right to exercise such rights and/or cause such rights held by such holder to become void; (v) provisions which
2
permit CVS Health to redeem or exchange such rights; and (vi) the appointment of the rights agent with respect to such rights. This provision is intended to confirm the board’s exclusive authority to issue, repurchase, redeem, terminate or amend share purchase rights or other rights to purchase shares or securities of CVS Health or any other corporation.
Stockholder
Action by Written Consent
The Charter provides that stockholder action may be taken at an annual or special meeting of stockholders or by written consent in lieu of a meeting, but only if such action is taken in accordance with the provisions of the Charter and By-Laws. Any person other than CVS Health seeking to have the CVS Health stockholders authorize or take corporate action by written consent without a meeting is required to deliver a written notice signed by holders of record of at least twenty-five percent (25%) of the voting power of the outstanding capital stock of CVS Health entitled to express consent on the relevant action and request that a record date be fixed for such purpose.
Stockholder Vote on Fundamental or Extraordinary Corporate Transactions
Under
Delaware law, a sale, lease or exchange of all or substantially all of CVS Health’s assets, an amendment to the Charter, a merger or consolidation of CVS Health with another corporation or a dissolution of CVS Health generally requires the affirmative vote of the board and, with limited exceptions, the affirmative vote of a majority of the aggregate voting power of the outstanding stock entitled to vote on the transaction.
With respect to transactions with related persons (persons who own at least 10% of the outstanding capital stock of CVS Health), the Charter provides that a majority of outstanding shares (excluding those owned by the related person) voting as a single class is required to approve a business combination transaction with a related person, unless (i) such transaction is approved by a majority of continuing directors (directors who are not the related person, or an affiliate or associate thereof (or a representative
or nominee of the related person or such affiliate or associate), that is involved in the relevant business combination and (a) who were members of the board immediately prior to the time that such related person became a related person or (b) whose initial election as a director was recommended by the affirmative vote of a least a majority of the continuing directors then in office, provided that, in either such case, such continuing director has continued in office after becoming a continuing director) or (ii) certain fair price requirements are met.
State Anti-Takeover Provisions
CVS Health has not opted out of Section 203 of the Delaware General Corporation Law, which provides that, if a person acquires 15% or more of the outstanding voting stock of a Delaware corporation, thereby becoming an “interested stockholder,” that person may
not engage in certain “business combinations” with the corporation, including mergers, purchases and sales of 10% or more of its assets, stock purchases and other transactions pursuant to which the percentage of the corporation’s stock owned by the interested stockholder increases (other than on a pro rata basis) or pursuant to which the interested stockholder receives a financial benefit from the corporation, for a period of three years after becoming an interested stockholder unless one of the following exceptions applies: (i) the board approved the acquisition of stock pursuant to which the person became an interested stockholder or the transaction that resulted in the person becoming an interested stockholder prior to the time that the person became an interested stockholder; (ii) upon consummation of the transaction that resulted in the person becoming an interested stockholder such person owned at least 85% of the outstanding voting stock of CVS Health,
excluding, for purposes of determining the voting stock outstanding, voting stock owned by directors who are also officers and certain employee stock plans; or (iii) the transaction is approved by the board and by the affirmative vote of two-thirds of the outstanding voting stock which is not owned by the interested stockholder. An “interested stockholder” also includes the affiliates and associates of a 15% or more owner and any affiliate or associate of CVS Health who was the owner of 15% or more of the outstanding voting stock within the three-year period prior to determine whether a person is an interested stockholder.
3
Dates Referenced Herein and Documents Incorporated by Reference
